- LatestEradication of female genital mutilation "a matter of resources"
- LatestHuman rights organisations call for EU action to combat female genital mutilation
- LatestPatau and Edwards syndromes 'can be identified at 10 weeks' gestation'
- LatestFIGO supports 2012’s International Day of Zero Tolerance to Female Genital Mutilation (6 February 2012)
- LatestAbstract Submission and ‘Early Registration’ fee deadline dates extended for FIGO 2012 World Congress
- LatestApplication process now open: FIGO/Olympus training courses in minimally invasive surgical techniques
HPV supplement
A special supplement of IJGO on the subject of HPV is available below free of charge. Click here to download the relevant software if required.
Biology of genital human papillomaviruses
The epidemiology of human papillomavirus infection and its association with cervical cancer
Pathology of HPV infection at the cytologic and histologic levels: Basis for a 2-tiered morphologic classification system
Clinical manifestations of HPV infection - Section A: Benign manifestations of HPV infection A1. Anogenital condylomas
HPV infection and HPV-associated neoplasia in immunocompromised women
Secondary prevention of cervical cancer
Methods for detection of HPV infection and its clinical utility
HPV vaccines
Delivering HPV vaccine in the industrial and developing world: the role of the ob-gyn community
A public health approach to cervical cancer control: Considerations of screening and vaccination strategies
How to manage and communicate with patients about HPV


![Sift.com [Opens in a new window]](/sites/www.figo.org/themes/figocorp/images/footer-sift-logo.gif)